Among patients with advanced NSCLC who received PD-1/PD-L1 ICIs in combination or without chemotherapy, MTVwb was an independent influencing factor for DCB, PFS, and OS. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.